Climb Bio annual total assets
2020
2021
2022
2023
2024
2025
Climb Bio Total Assets Growth & History (CLYM)
Climb Bio's total assets was $167.7M for fiscal 2025.
View full Climb Bio company overviewClimb Bio annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $167.7M | −$49.4M | −22.77% |
| 2024 | 2024-12-31 | $217.2M | $106.7M | +96.60% |
| 2023 | 2023-12-31 | $110.5M | −$24.5M | −18.17% |
| 2022 | 2022-12-31 | $135.0M | −$38.2M | −22.08% |
| 2021 | 2021-12-31 | $173.2M | $148.6M | +603.35% |
| 2020 | 2020-12-31 | $24.6M | — | — |
Climb Bio quarterly total assets
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $246.3M | $53.9M | +28.02% |
| Q1 2026 | 2026-03-31 | $152.4M | −$48.4M | −24.09% |
| Q4 2025 | 2025-12-31 | $167.7M | −$49.4M | −22.77% |
| Q3 2025 | 2025-09-30 | $182.3M | −$39.9M | −17.95% |
| Q2 2025 | 2025-06-30 | $192.4M | −$33.6M | −14.88% |
| Q1 2025 | 2025-03-31 | $200.7M | $91.4M | +83.60% |
| Q4 2024 | 2024-12-31 | $217.2M | $106.7M | +96.60% |
| Q3 2024 | 2024-09-30 | $222.2M | $109.5M | +97.10% |
| Q2 2024 | 2024-06-30 | $226.0M | $109.7M | +94.38% |
| Q1 2024 | 2024-03-31 | $109.3M | −$12.8M | −10.44% |
| Q4 2023 | 2023-12-31 | $110.5M | −$24.5M | −18.17% |
| Q3 2023 | 2023-09-30 | $112.7M | −$28.1M | −19.97% |
| Q2 2023 | 2023-06-30 | $116.3M | −$33.8M | −22.54% |
| Q1 2023 | 2023-03-31 | $122.1M | −$40.3M | −24.83% |
| Q4 2022 | 2022-12-31 | $135.0M | −$38.2M | −22.08% |
| Q3 2022 | 2022-09-30 | $140.9M | −$41.4M | −22.71% |
| Q2 2022 | 2022-06-30 | $150.1M | $42.5M | +39.47% |
| Q1 2022 | 2022-03-31 | $162.4M | — | — |
| Q4 2021 | 2021-12-31 | $173.2M | $148.6M | +603.35% |
| Q3 2021 | 2021-09-30 | $182.3M | — | — |
| Q2 2021 | 2021-06-30 | $107.6M | — | — |
| Q4 2020 | 2020-12-31 | $24.6M | — | — |
Climb Bio total assets trends
Over the last five fiscal years, Climb Bio's total assets increased from $24.6M to $167.7M, a change of $143.1M. The latest reported quarter, Q2 2026, shows $246.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Climb Bio source filings ↗